Patent Assignment
Reel/Frame 053020/0143
Change of Name
Recorded: 2020-06-23
Pages: 7
Assignor
ALDER BIOPHARMACEUTICALS, INC.
Executed: 2019-11-04
Assignee
LUNDBECK SEATTLE BIOPHARMACEUTICALS, INC.
11804 NORTH CREEK PARKWAY SOUTH, BOTHELL, WASHINGTON, 98011
Covered Properties
(111)
Culture Method for Obtaining a Clonal Population of Antigen-Specific B Cells
PCT:
PCT/US2007/011980 ↗
Antibodies to Tnf Alpha and Use Thereof
PCT:
PCT/US2008/064414 ↗
Antibodies to Il-6 and Use Thereof
PCT:
PCT/US2008/064432 ↗
Antagonists of Il-6 to Raise Albumin and/or Lower Crp
PCT:
PCT/US2009/006257 ↗
Antagonists of Il-6 to Prevent or Treat Thrombosis
PCT:
PCT/US2009/006266 ↗
Antagonists of Il-6 to Prevent or Treat Cachexia, Weakness, Fatigue, and/or Fever
PCT:
PCT/US2009/006273 ↗
Antibodies to Il-6 and Use Thereof
PCT:
PCT/US2009/006274 ↗
Antagonists of Il-6 to Raise Albumin and/or Lower Crp
PCT:
PCT/US2010/057978 ↗
Antibodies to Il-6 and Use Thereof
PCT:
PCT/US2010/057981 ↗
Antagonists of Il-6 to Prevent or Treat Cachexia, Weakness, Fatigue, and/or Fever
PCT:
PCT/US2010/057986 ↗
Antagonists of Il-6 to Prevent or Treat Thrombosis
PCT:
PCT/US2010/057990 ↗
Anti-Il-6 Antibodies for the Treatment of Oral Mucositis
PCT:
PCT/US2011/062121 ↗
Anti-Il-6 Antibodies for the Treatment of Anemia
PCT:
PCT/US2011/062131 ↗
Antibodies to Hgf and Compositions Containing
PCT:
PCT/US2014/029163 ↗
Therapeutic Use of Antibodies to Hgf
PCT:
PCT/US2014/029383 ↗
Regulation of Glucose Metabolism Using Anti-Cgrp Antibodies
PCT:
PCT/US2014/045389 ↗
Anti-Il-6 Antibodies for the Treatment of Psoriatic Arthritis
PCT:
PCT/US2014/059543 ↗
Anti-Glycoprotein Antibodies and Uses Thereof
PCT:
PCT/US2016/013701 ↗
Use of Anti-Pacap Antibodies and Antigen Binding Fragments Thereof for Treatment, Prevention, or Inhibition of Photophobia
PCT:
PCT/US2016/027977 ↗
Use of Anti-Pacap Antibodies and Antigen Binding Fragments Thereof for Treatment, Prevention, or Inhibition of Photophobia
PCT:
PCT/US2016/027981 ↗
Acute Treatment and Rapid Treatment of Headache Using Anti-Cgrp Antibodies
PCT:
PCT/US2020/012781 ↗
Treatment of Medication Overuse Headache Using Anti-Cgrp or Anti-Cgrp-R Antibodies
PCT:
PCT/US2020/012790 ↗
Antibodies to TNF alpha and use thereof
Antibodies to Il-6 and Use Thereof
Antagonists of Il-6 to Raise Albumin and/or Lower Crp
Antagonists of Il-6 to Prevent or Treat Cachexia, Weakness, Fatigue, and/or Fever
Antagonists of Il-6 to Prevent or Treat Thrombosis
Nucleic Acids Encoding Antibodies to Il-6, and Recombinant Production of Anti-Il-6 Antibodies
Use of Anti-Il-6 Antibodies Having Specific Binding Properties to Treat Cachexia
Antibodies to Il-6 and Use Thereof
Treating Anemia Using Il-6 Antibodies Having Particular Epitopic Specificity
Application:
12/601,295 →
Publication:
US 2010/0290993
Methods of Treating or Diagnosing Conditions Associated with Elevated Il-6 Using Anti-Il-6 Antibodies or Fragments
Methods of Treating Anemia Using Anti-Il-6 Antibodies
Antagonists of Il-6 to Prevent or Treat Thrombosis
Antagonists of Il-6 to Raise Albumin and/or Lower Crp
Antagonists of Il-6 to Prevent or Treat Cachexia, Weakness, Fatigue, and/or Fever
Nucleic Acids Encoding Anti-Il-6 Antibodies of Defined Epitopic Specificity
Methods of Reducing Crp and/or Increasing Serum Albumin in Patients in Need Using Il-6 Antibodies of Defined Epitopic Specificity
Antibodies to Il-6 and Use Thereof
Application:
13/277,390 →
Publication:
US 2012/0142900
Nucleic acids encoding anti-IL-6 antibodies of defined epitopic specificity
Application:
13/298,407 →
Publication:
US 2013/0017575
Anti-Il-6 Antibodies for the Treatment of Oral Mucositis
Anti-Il-6 Antibodies for the Treatment of Arthritis
Anti-Il-6 Antibodies for the Treatment of Anemia
Anti-IL-6 antibodies or fragments thereof to treat or inhibit cachexia, associated with chemotherapy toxicity
Antagonists of Il-6 to Prevent or Treat Thrombosis
Antagonists of Il-6 to Raise Albumin and/or Lower Crp
Application:
13/511,409 →
Publication:
US 2012/0294852
Subcutaneously Administrable Composition Containing Anti-Il-6 Antibody
Antagonists of Il-6 to Prevent or Treat Thrombosis
Antagonists of Il-6 to Prevent or Treat Thrombosis
Antagonists of Il-6 to Treat Cachexia, Weakness, Fatigue , and/or Fever
Antibodies to Il-6 to Inhibit or Treat Inflammation
Antagonists of IL-6 to raise albumin and/or lower crp
Antagonists of Il-6 to Raise Albumin and/or Lower Crp
Method of Improving Patient Survivability and Quality of Life by Anti-Il-6 Antibody Administration
Antibodies to Hgf and Compositions Containing
Antibodies to Il-6 and Use Thereof
A Method of Improving Patient Survivability and Quality of Life by Administering an Anti-Il-6 Antibody
Expression Vectors Containing Isolated Nucleic Acids Encoding Anti-Human IL-6 Antibody
Treating Anemia in Chronic Il-6 Associated Diseases Using Anti-Il-6 Antibodies
Anti-Il-6 Antibodies for the Treatment of Oral Mucositis
Anti-Il-6 Antibody for Use in the Treatment of Cachexia
Isolated Anti-Il-6 Antibodies
Antagonists of Il-6 to Prevent or Treat Thrombosis
Antibodies to Il-6 and Use Thereof
Antibodies to Tnf Alpha and Use Thereof
Antibodies to Il-6 and Use Thereof
Antagonists of Il-6 to Prevent or Treat Cachexia, Weakness, Fatigue, and/or Fever
Dosing Regimens Using Anti-Il-6 Antibodies for the Treatment of Rheumatoid and Psoriatic Arthritis
Application:
14/876,376 →
Publication:
US 2016/0130340
Antagonists of Il-6 to Prevent or Treat Thrombosis
Antagonists to IL-6 to Raise Albumin and/or Lower CRP
Antagonists of Il-6 to Raise Albumin and/or Lower Crp
Anti-Il-6 Antibodies for the Treatment of Anemia
Application:
15/055,005 →
Publication:
US 2016/0340423
Use of Anti-Pacap Antibodies and Antigen Binding Fragments Thereof for Treatment, Prevention, or Inhibition of Photophobia
Use of Anti-Pacap Antibodies and Antigen Binding Fragments Thereof for Treatment, Prevention, or Inhibition of Photophobia
Application:
15/130,658 →
Publication:
US 2016/0376363
Antibodies to Hgf and Compositions Containing
Antagonists of Il-6 to Prevent or Treat Cachexia, Weakness, Fatigue, and/or Fever
Anti-Glycoprotein Antibodies and Uses Thereof
Application:
15/544,163 →
Publication:
US 2018/0142038
Antagonists of Il-6 to Raise Albumin and/or Lower Crp
Methods of Treating Autoimmunity Using Specific Anti-Il-6 Antibodies
Anti-Il-6 Antibodies for the Treatment of Arthritis
Method of Treating Allergic Asthma with Antibodies to Il-6
Antagonists of Il-6 to Prevent or Treat Cachexia, Weakness, Fatigue, and/or Fever
Application:
15/797,209 →
Publication:
US 2018/0117149
Antagonists of Il-6 to Prevent or Treat Thrombosis
Anti-Il-6 Antibodies for the Treatment of Oral Mucositis
Application:
15/951,337 →
Publication:
US 2019/0023780
Antagonists of Il-6 to Prevent or Treat Thrombosis
Antibodies to Hgf and Compositions Containing
Application:
16/158,584 →
Publication:
US 2019/0085066
Antagonists of Il-6 to Prevent or Treat Cachexia, Weakness, Fatigue, and/or Fever
Application:
16/191,514 →
Publication:
US 2019/0270805
Methods of Determining Whether Anti-Pacap Antibodies Inhibit Pacap-Associated Photophobia or Light Aversion
Antibodies to Il-6 and Use Thereof
Application:
16/550,625 →
Publication:
US 2020/0108140
Antagonists of Il-6 to Raise Albumin and/or Lower Crp
Application:
16/591,668 →
Publication:
US 2020/0093921
Methods of isolating antigen-specific cells and producing antibodies therefrom
Application:
60/801,412 →
Antibodies to IL6
Application:
60/924,550 →
Antibodies to TNF alpha
Application:
60/924,551 →
Antagonists of IL-6 to raise Albumin and/or lower CRP
Application:
61/117,811 →
Antagonists of IL-6 to prevent or treat Cachexia, weakness, fatigue, and/or fever
Application:
61/117,839 →
Antagonists of IL-6 to prevent or treat Thrombosis
Application:
61/117,861 →
Antibodies to Il-6 and Use Thereof
Application:
61/325,547 →
Antibodies to Il-6 and Use Thereof
Application:
61/355,819 →
Antibodies to Il-6 and Use Thereof
Application:
61/358,615 →
Antibodies to Il-6 and Use Thereof
Application:
61/410,169 →
Antagonists of Il-6 to Prevent or Treat Cachexia, Weakness, Fatigue, and/or Fever
Application:
61/416,332 →
Antibodies to Il-6 and Use Thereof
Application:
61/416,343 →
Antagonists of Il-6 to Raise Albumin and/or Lower Crp
Application:
61/416,351 →
Antagonists of Il-6 to Prevent or Treat Thrombosis
Application:
61/416,363 →
Antibodies to Il-6 and Use Thereof
Application:
61/489,857 →
Antibodies to Il-6 and Use Thereof
Application:
61/511,797 →
Therapeutic Use of Antibodies to Hgf
Application:
61/781,643 →
Antibodies to Hgf and Compositions Containing
Application:
61/782,868 →
Anti-Il-6 Antibodies for the Treatment of Psoriatic Arthritis
Application:
61/887,666 →
Dosing Regimens Using Anti-Il-6 Antibodies for the Treatment of Rheumatoid and Psoriatic Arthritis
Application:
62/060,797 →
Anti-Glycoprotein Antibodies and Uses Thereof
Application:
62/104,407 →
Related Assignments
(24)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 12, 2010
From: GARCIA-MARTINEZ, LEON; JENSEN, ANNE ELIZABETH CARVALHO; OLSON, KATIE; DUTZAR, BEN
To: ALDER BIOPHARMACEUTICALS, INC.
Reel/Frame 023763/0347 →
Corrective Assignment to Correct the Assignee's Name in Non-Us Cases Only Previously Recorded on Reel 025681 Frame 0634. Assignor(S) Hereby Confirms the Conveyance of Non-Us Rights of Patents Relating to Applications Listed in Assignment..
Nov 28, 2012
From: ALDERBIO HOLDINGS LLC
To: BRISTOL-MYERS SQUIBB COMPANY
Reel/Frame 029372/0056 →
Corrective Assignment to Correct the Spelling of Inventor Anne Elisabeth Carvalho Jensen's Name Previously Recorded on Reel 023763 Frame 0347. Assignor(S) Hereby Confirms the Assignment of Assignors' Interest.
Feb 5, 2014
From: GARCIA-MARTINEZ, LEON; CARVALHO JENSEN, ANNE ELISABETH; OLSON, KATIE; DUTZAR, BEN
To: ALDER BIOPHARMACEUTICALS, INC.
Reel/Frame 032231/0411 →
Corrective Assignment to Correct the Spelling and Punctuation of Inventor Anne Elisabeth Carvalho Jensen Previously Recorded on Reel 022149 Frame 0275. Assignor(S) Hereby Confirms the Assignment of Assignors' Interest..
Feb 5, 2014
From: OLSON, KATIE; DUTZAR, BEN; CARVALHO JENSEN, ANNE ELISABETH; GARCIA-MARTINEZ, LEON
To: ALDER BIOPHARMACEUTICALS, INC.
Reel/Frame 032162/0067 →
Corrective Assignment to Correct the Second Assignor's Name to Correctly Read Carvalho Jensen, Anne Elisabeth Previously Recorded on Reel 024029 Frame 0749. Assignor(S) Hereby Confirms the Assignment of Assignors' Interest.
Feb 5, 2014
From: GARCIA-MARTINEZ, LEON; CARVALHO JENSEN, ANNE ELISABETH; OLSON, KATIE; DUTZAR, BEN
To: ALDER BIOPHARMACEUTICALS, INC.
Reel/Frame 032161/0983 →
Corrective Assignment to Correct the Assignee's Name to Correctly Read Alder Biopharmaceuticals, Inc. Previously Recorded on Reel 022264 Frame 0501. Assignor(S) Hereby Confirms the Assignment of Assignors' Interest.
Feb 5, 2014
From: SMITH, JEFFREY T.L.
To: ALDER BIOPHARMACEUTICALS, INC.
Reel/Frame 032161/0853 →
Corrective Assignment to Correct the the Second Assignor's Name to Correctly Read Carvalho Jensen, Anne Elisabeth Previously Recorded on Reel 022155 Frame 0247. Assignor(S) Hereby Confirms the Assignment of Assignors' Interest.
Feb 5, 2014
From: GARCIA-MARTINEZ, LEON; CARVALHO JENSEN, ANNE ELISABETH; OLSON, KATIE; DUTZAR, BEN
To: ALDER BIOPHARMACEUTICALS, INC.
Reel/Frame 032161/0840 →
Assignment of Assignor's Interest
Feb 24, 2014
From: BRISTOL-MYERS SQUIBB COMPANY
To: ALDERBIO HOLDINGS LLC
Reel/Frame 032329/0931 →
Assignment of 1/2 Interest in Non-U.S. Applications
Feb 25, 2014
From: ALDERBIO HOLDINGS LLC
To: BRISTOL-MYERS SQUIBB COMPANY
Reel/Frame 032332/0787 →
Assignment of Assignor's Interest
Dec 12, 2014
From: BRISTOL-MYERS SQUIBB COMPANY
To: ALDERBIO HOLDINGS LLC
Reel/Frame 034491/0663 →
Assignment of Assignor's Interest
Jan 16, 2015
From: BRISTOL-MYERS SQUIBB COMPANY
To: ALDERBIO HOLDINGS LLC
Reel/Frame 034777/0728 →
Assignment of Assignor's Interest
Apr 12, 2016
From: SMITH, JEFFREY T.L.
To: ALDER BIOPHARMACEUTICALS, INC.
Reel/Frame 038258/0380 →
Assignment of Assignor's Interest
Apr 12, 2016
From: BAKER, BRIAN; SMITH, JEFFREY T.L.; LATHAM, JOHN A.
To: ALDER BIOPHARMACEUTICALS, INC.
Reel/Frame 038258/0094 →
Assignment of Assignor's Interest
Jun 27, 2017
From: KUBURAS, ADISA; MASON, BIANCA; SOWERS, LEVI P.; RUSSO, ANDREW F.
To: THE UNIVERSITY OF IOWA RESEARCH FOUNDATION
Reel/Frame 042822/0379 →
Assignment of Assignor's Interest
Aug 11, 2017
From: ALLISON, DANIEL S.; HENDRIX, KATHERINE LEE; OJALA, ETHAN W.; FAN, PEI
To: ALDER BIOPHARMACEUTICALS, INC.,
Reel/Frame 043271/0576 →
Assignment of Assignor's Interest
Feb 28, 2019
From: FELDHAUS, ANDREW L.
To: ALDER BIOPHARMACEUTICALS, INC.
Reel/Frame 048465/0692 →
Assignment of Assignor's Interest
Apr 4, 2019
From: ALDER BIOPHARMACEUTICALS, INC.
To: ALDERBIO HOLDINGS LLC
Reel/Frame 048796/0378 →
Assignment of Assignor's Interest
Aug 30, 2019
From: BRISTOL-MYERS SQUIBB COMPANY
To: ALDERBIO HOLDINGS LLC
Reel/Frame 050219/0441 →
Assignment of Assignor's Interest
Aug 30, 2019
From: BRISTOL-MYERS SQUIBB COMPANY
To: ALDERBIO HOLDINGS LLC
Reel/Frame 050222/0600 →
Assignment of Assignor's Interest
Jun 23, 2020
From: LUNDBECK SEATTLE BIOPHARMACEUTICALS, INC
To: H. LUNDBECK A/S
Reel/Frame 053020/0205 →
Assignment of Assignor's Interest
Aug 14, 2020
From: H. LUNDBECK A/S
To: VITAERIS INC.
Reel/Frame 053496/0319 →
Assignment of Assignor's Interest
Sep 3, 2020
From: LUNDBECK SEATTLE BIOPHARMACEUTICALS, INC
To: H. LUNDBECK A/S.
Reel/Frame 054161/0877 →
Change of Name
Sep 3, 2020
From: ALDER BIOPHARMACEUTICALS, INC
To: LUNDBECK SEATTLE BIOPHARMACEUTICALS, INC
Reel/Frame 053681/0224 →
Corrective Assignment to Correct the Assignee Name Previously Recorded at Reel: 054161 Frame: 0877. Assignor(S) Hereby Confirms the Assignment.
Jun 2, 2021
From: LUNDBECK SEATTLE BIOPHARMACEUTICALS, INC
To: H. LUNDBECK A/S
Reel/Frame 056449/0543 →